©The Author(s) 2025.
World J Gastrointest Surg. Sep 27, 2025; 17(9): 109980
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.109980
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.109980
Figure 5 Variation of general condition.
aP < 0.05 compared with baseline values, representing low-dose group. A: Weight of participant; B: Child-Pugh score; C: Model for End-Stage Liver Disease score. MELD: Model for End-Stage Liver Disease.
- Citation: Qin X, Chen J, Zhang HN, Du L, Ma Y, Li Y, Lu Y, Wang YT, Wu LF, Yu ZH, Hu MJ, Li LJ, Liao B, Li Z, Yang ZY, Li K, Yuan YF. Treatment of human umbilical cord-derived mesenchymal stem cells for hepatitis B virus-associated decompensated liver cirrhosis: A clinical trial. World J Gastrointest Surg 2025; 17(9): 109980
- URL: https://www.wjgnet.com/1948-9366/full/v17/i9/109980.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i9.109980